Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Upstream use of tirofiban in patients admitted for an acute coronary syndrome in hospitals with or without facilities for invasive management. PRISM-PLUS Investigators.
Théroux P, Alexander J Jr, Dupuis J, Pesant Y, Gervais P, Grandmont D, Kouz S, Laramée P, Huynh T, Barr E, Sax FL; PRISM-PLUS Investigators. Théroux P, et al. Am J Cardiol. 2001 Feb 15;87(4):375-80. doi: 10.1016/s0002-9149(00)01386-2. Am J Cardiol. 2001. PMID: 11179517 Clinical Trial.
Combination therapy with tirofiban and enoxaparin in acute coronary syndromes.
Cohen M, Théroux P, Weber S, Laramée P, Huynh T, Borzak S, Diodati JG, Squire IB, Deckelbaum LI, Thornton AR, Harris KE, Sax FL, Lo MW, White HD. Cohen M, et al. Among authors: theroux p. Int J Cardiol. 1999 Dec 1;71(3):273-81. doi: 10.1016/s0167-5273(99)00171-0. Int J Cardiol. 1999. PMID: 10636535 Clinical Trial.
Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study.
Théroux P, Alexander J Jr, Pharand C, Barr E, Snapinn S, Ghannam AF, Sax FL. Théroux P, et al. Circulation. 2000 Nov 14;102(20):2466-72. doi: 10.1161/01.cir.102.20.2466. Circulation. 2000. PMID: 11076818 Clinical Trial.
Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators.
Zhao XQ, Théroux P, Snapinn SM, Sax FL. Zhao XQ, et al. Among authors: theroux p. Circulation. 1999 Oct 12;100(15):1609-15. doi: 10.1161/01.cir.100.15.1609. Circulation. 1999. PMID: 10517731 Clinical Trial.
Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty.
Doucet S, Malekianpour M, Théroux P, Bilodeau L, Côté G, de Guise P, Dupuis J, Joyal M, Gosselin G, Tanguay JF, Juneau M, Harel F, Nattel S, Tardif JC, Lespérance J. Doucet S, et al. Among authors: theroux p. Circulation. 2000 Mar 7;101(9):955-61. doi: 10.1161/01.cir.101.9.955. Circulation. 2000. PMID: 10704160 Clinical Trial.
339 results